AITechCrunchabout 2 hours ago
Vivodyne's HIVE Labs Target AI Drug Data Gap
1 min read
Vivodyne's HIVE robotic labs grow 20 human tissue types to generate causal biological data for AI drug discovery. The company claims liver cells achieve 94% predictive accuracy versus human trials. Vivodyne opened a 'human data center' near San Francisco and has raised nearly $80 million led by Khosla Ventures.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
